Obesity and Its Potential Effects on Antidepressant Treatment Outcomes in Patients with Depressive Disorders: A Literature Review

International Journal of Molecular Sciences
Young Sup WooWon-Myong Bahk

Abstract

Accumulating evidence regarding clinical, neurobiological, genetic, and environmental factors suggests a bidirectional link between obesity and depressive disorders. Although a few studies have investigated the link between obesity/excess body weight and the response to antidepressants in depressive disorders, the effect of weight on treatment response remains poorly understood. In this review, we summarized recent data regarding the relationship between the response to antidepressants and obesity/excess body weight in clinical studies of patients with depressive disorders. Although several studies indicated an association between obesity/excess body weight and poor antidepressant responses, it is difficult to draw definitive conclusions due to the variability of subject composition and methodological differences among studies. Especially, differences in sex, age and menopausal status, depressive symptom subtypes, and antidepressants administered may have caused inconsistencies in the results among studies. The relationship between obesity/excess body weight and antidepressant responses should be investigated further in high-powered studies addressing the differential effects on subject characteristics and treatment. Moreover, ...Continue Reading

References

Jan 1, 1990·Journal of Neurochemistry·Z LackovićM Relja
Aug 11, 1987·Brain Research·B A MastersM K Raizada
Apr 1, 1995·Biological Psychiatry·U HalbreichK Wang
Apr 1, 1997·The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry·L S SchneiderB S Meyers
Oct 28, 1998·Proceedings of the National Academy of Sciences of the United States of America·D OngürJ L Price
Feb 7, 2001·The Journal of Biological Chemistry·S PugazhenthiJ E Reusch
Aug 31, 2000·The American Journal of Psychiatry·S G KornsteinM B Keller
Oct 18, 2000·European Journal of Pharmacology·P S D'AquilaG Serra
Nov 7, 2000·Biological Psychiatry·W C Drevets
Jun 22, 2001·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·F MartényiS Metcalfe
Sep 26, 2001·Archives of General Psychiatry·U OsbyP Sparén
Feb 7, 2002·Zeitschrift für Gerontologie und Geriatrie·S ArltU Beisiegel
Apr 16, 2002·Journal of Neurochemistry·Wen-Hua ZhengRémi Quirion
Jun 14, 2002·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Nick Z Lu, Cynthia L Bethea
Jul 2, 2002·Journal of Neurochemistry·Lian MaiXiaohua Li
Aug 23, 2002·European Archives of Psychiatry and Clinical Neuroscience·Franco Benazzi
Aug 30, 2002·Journal of Affective Disorders·Jules AngstKathleen Merikangas
Oct 16, 2002·Journal of Psychosomatic Research·Bruce S McEwenLawrence P Reagan
Nov 2, 2002·The American Journal of Psychiatry·Frederic M QuitkinDonald F Klein
Nov 6, 2002·The Journal of Biological Chemistry·Yong Hee LeeMorris F White
Nov 28, 2002·Progress in Neuro-psychopharmacology & Biological Psychiatry·Francesco BenedettiEnrico Smeraldi
Dec 14, 2002·The American Journal of Cardiology·Gregory E MillerWilliam A Banks
Apr 18, 2003·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Younger W-Y YuShih-Jen Tsai
May 8, 2003·Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Métabolisme·G HeB Richelsen
Jun 5, 2003·The Psychiatric Clinics of North America·Andrew A Nierenberg
Jun 6, 2003·The Journal of Clinical Endocrinology and Metabolism·Molly C Carr
Aug 2, 2003·Biological Psychiatry·Dominique L MusselmanLawrence S Phillips
Oct 11, 2003·Journal of Affective Disorders·Leslie Westlund Tam, Barbara L Parry
Feb 26, 2004·Lancet Neurology·Suzanne Craft, G Stennis Watson
Sep 14, 2004·The International Journal of Neuropsychopharmacology·George I PapakostasMaurizio Fava
Dec 31, 2004·The American Journal of Psychiatry·Alan J ThomasJohn T O'Brien

❮ Previous
Next ❯

Citations

Jun 10, 2016·Expert Opinion on Pharmacotherapy·Susan L McElroyPaul E Keck
Oct 7, 2017·The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry·Seetal DoddMichael Berk
Sep 19, 2019·Journal of Health Psychology·Thelma Beatriz González-CastroPedro Iván Arias-Vázquez
Mar 12, 2020·Psychiatry Investigation·Giampaolo PernaDaniela Caldirola
Jul 13, 2016·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Lucile CapuronNathalie Castanon
Aug 16, 2018·Frontiers in Endocrinology·Silvia R S OuakininCarlos J Gois
Nov 30, 2019·Neurotoxicity Research·Katarzyna GłombikBogusława Budziszewska
Jul 29, 2020·Journal of Clinical Medicine·Francesco WeissGiulio Perugi
May 16, 2019·International Journal of Obesity : Journal of the International Association for the Study of Obesity·Jordan N KohnSuzi Hong
Jan 1, 2019·Chronic Stress·Jeffrey F Scherrer, Patrick J Lustman
Oct 28, 2018·Journal of Psychiatric Research·Steven D TargumI David MacDonald

❮ Previous
Next ❯

Related Concepts

Related Feeds

Amygdala: Sensory Processes

Amygdalae, nuclei clusters located in the temporal lobe of the brain, play a role in memory, emotional responses, and decision-making. Here is the latest research on sensory processes in the amygdala.

AKT Pathway

This feed focuses on the AKT serine/threonine kinase, which is an important signaling pathway involved in processes such as glucose metabolism and cell survival.

Amygdala and Midbrain Dopamine

The midbrain dopamine system is widely studied for its involvement in emotional and motivational behavior. Some of these neurons receive information from the amygdala and project throughout the cortex. When the circuit and transmission of dopamine is disrupted symptoms may present. Here is the latest research on the amygdala and midbrain dopamine.

Bipolar Disorder

Bipolar disorder is characterized by manic and/or depressive episodes and associated with uncommon shifts in mood, activity levels, and energy. Discover the latest research this illness here.

Astrocytes

Astrocytes are glial cells that support the blood-brain barrier, facilitate neurotransmission, provide nutrients to neurons, and help repair damaged nervous tissues. Here is the latest research.

Astrocytes & Neurodegeneration

Astrocytes are important for the health and function of the central nervous system. When these cells stop functioning properly, either through gain of function or loss of homeostatic controls, neurodegenerative diseases can occur. Here is the latest research on astrocytes and neurodegeneration.

Astrocytes in Repair & Regeneration

Astrocytes are glial cells found within the CNS and are able to regenerate new neurons. They become activated during CNS injury and disease. The activation leads to the transcription of new genes and the repair and regeneration of neurons. Discover the latest research on astrocytes in repair and regeneration here.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis